Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S R Riddell

Showing results (11-20 of 72) with videos related to

Pageof 8
Sort By:
Annual Review of Immunology|January 1, 1995
Principles for adoptive T cell therapy of human viral diseasesS R Riddell, P D Greenberg
Reviews of Infectious Diseases|November 1, 1991
Cytotoxic T cells specific for cytomegalovirus: a potential therapy for immunocompromised patientsS R Riddell, P Reusser, P D Greenberg
Current Opinion in Immunology|November 22, 1997
Prospects for adoptive T cell therapyC Yee, S R Riddell, P D Greenberg
Current Opinion in Immunology|March 3, 2001
In vivo tracking of tumor-specific T cellsC Yee, S R Riddell, P D Greenberg
Chinese Medical Journal|May 1, 1997
Human cytomegalovirus matrix protein PP150 is efficiently presented as one of target antigens for cytotoxic T lymphocyte recognitionC Li, X Yang, W Tu, et al.
Clinical Pharmacology and Therapeutics|May 13, 2016
CD19-Targeted chimeric antigen receptor-modified T-cell immunotherapy for B-cell malignanciesC J Turtle, S R Riddell, D G Maloney
Journal of Medical Primatology|November 4, 2010
A non-human primate model for analysis of safety, persistence, and function of adoptively transferred T cellsC Berger, M Berger, D Anderson, et al.
Current Opinion in Immunology|August 1, 1993
CD8+ cytotoxic T cell therapy of cytomegalovirus and HIV infectionS R Riddell, M J Gilbert, P D Greenberg
Blood|April 16, 1998
Cytotoxic T-lymphocyte-defined human minor histocompatibility antigens with a restricted tissue distributionE H Warren, P D Greenberg, S R Riddell
Current Opinion in Hematology|November 14, 1998
Minor histocompatibility antigens as targets for T-cell therapy after bone marrow transplantationE H Warren, M Gavin, P D Greenberg, et al.
Pageof 8

Showing results (11-20 of 72) with videos related to

Sort By:
Pageof 8
Annual Review of Immunology|January 1, 1995
Principles for adoptive T cell therapy of human viral diseasesS R Riddell, P D Greenberg
Reviews of Infectious Diseases|November 1, 1991
Cytotoxic T cells specific for cytomegalovirus: a potential therapy for immunocompromised patientsS R Riddell, P Reusser, P D Greenberg
Current Opinion in Immunology|November 22, 1997
Prospects for adoptive T cell therapyC Yee, S R Riddell, P D Greenberg
Current Opinion in Immunology|March 3, 2001
In vivo tracking of tumor-specific T cellsC Yee, S R Riddell, P D Greenberg
Chinese Medical Journal|May 1, 1997
Human cytomegalovirus matrix protein PP150 is efficiently presented as one of target antigens for cytotoxic T lymphocyte recognitionC Li, X Yang, W Tu, et al.
Clinical Pharmacology and Therapeutics|May 13, 2016
CD19-Targeted chimeric antigen receptor-modified T-cell immunotherapy for B-cell malignanciesC J Turtle, S R Riddell, D G Maloney
Journal of Medical Primatology|November 4, 2010
A non-human primate model for analysis of safety, persistence, and function of adoptively transferred T cellsC Berger, M Berger, D Anderson, et al.
Current Opinion in Immunology|August 1, 1993
CD8+ cytotoxic T cell therapy of cytomegalovirus and HIV infectionS R Riddell, M J Gilbert, P D Greenberg
Blood|April 16, 1998
Cytotoxic T-lymphocyte-defined human minor histocompatibility antigens with a restricted tissue distributionE H Warren, P D Greenberg, S R Riddell
Current Opinion in Hematology|November 14, 1998
Minor histocompatibility antigens as targets for T-cell therapy after bone marrow transplantationE H Warren, M Gavin, P D Greenberg, et al.
Pageof 8